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the questionnaire in each country, and comparability of
data across countries.
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OBJECTIVES: While measurement of quality of life
(QoL) has become a vital part of assessing urinary incon-
tinence in women, linguistically validated language ver-
sions of a measure including questions on QoL, strategies
for coping and the severity of symptoms has not been
available. Prior to use in an international trial, the King’s
Health Questionnaire (KHQ) designed in UK English had
to undergo cross-cultural adaptation in eight languages. 
METHODS: The translation process of the KHQ, coor-
dinated by a QoL specialist in each target country, em-
ployed the following methodology: 1) two forward trans-
lations by professional translators, native speakers of the
target language and fluent in English; 2) comparison and
reconciliation of the translations by QoL specialist and
translators; 3) backward translation by a native English
speaker; 4) comparison of source and backward version;
5) comprehension test in a sample target population; 6)
international harmonization. 
RESULTS: Linguistic and conceptual issues emerged when
translating idiomatic English phrases and the original re-
sponse scales. No linguistic equivalent was available for
idiomatic expressions such as “waterworks infection” or
“make you feel bad about yourself” and the term “blad-
der” was revealed as being too technical during compre-
hension tests. Patient testing also showed that a response
option “not applicable” was lacking for certain questions.
To harmonize with the validated original however, no
changes were made in the response categories. 
CONCLUSIONS: A rigorous translation methodology
was performed to ensure conceptual equivalence and
cross-cultural acceptability of translations. Psychometric
testing will be conducted to ensure reliability and validity
in each translation. This work highlights the value of in-
tegrating international feedback into instrument design.
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Sirolimus (rapamycin), in combination with standard im-
munosuppressive therapy, significantly reduced the inci-
dence of acute rejection (AR) in a prospective trial in kid-
ney transplant recipients. The purpose of this study was
to determine the relationship between resource utilization
and the number of AR episodes. 
METHODS: Medical resource utilization data were col-
lected for 719 US patients enrolled in a randomized, dou-
ble-blind, controlled clinical trial. Patients were catego-
rized into three groups according to their experience of
AR (both biopsy confirmed and presumptive) during the
first 6 months post transplant: those who had no AR
(N  542), one AR episode (N  125), and two or more
AR episodes (N  52). Measures of medical resource uti-
lization were compared between groups. The measures
included mean hospital days, days on dialysis, and
amount of concomitant immunosuppressive rescue medi-
cations. Different immunosuppressive rescue drugs were
combined into a single measure in the analysis using cost
estimates based on average wholesale prices. 
RESULTS: Patients experiencing one AR episode had
higher resource utilization rates (18.8 hospital days, 10.6
days on dialysis, and $10,600 cost of concomitant immu-
nosuppressive rescue drugs) compared with those experi-
encing none (12.6 hospital days, 1.7 days on dialysis, and
$1400 of rescue drugs). Patients with multiple AR epi-
sodes had the highest rates of resource utilization (20.5
days of hospitalization, 10.4 days on dialysis, and $16,600
of concomitant immunosuppressive rescue drugs). All
three-way differences were significant at the .05 level
based on F-tests. 
CONCLUSIONS: AR episodes in kidney transplant pa-
tients were associated with higher utilization of resources
during the first six months post-transplantation. A reduc-
tion in the AR rate by sirolimus may offer both improved
economic as well as clinical outcomes.
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OBJECTIVE: A cost-effectiveness analysis comparison of
mycophenolate mofetil, a new immunosuppressant, and
muromonab CD3 in patients with intractable acute rejec-
tion after renal transplantation was conducted. 
METHODS: A clinical decision analytic model was cre-
ated based upon their use in Nagoya Second Red Cross
Hospital. This study was analyzed from the payer’s per-
spective. The cost data were obtained from the center
based on what would be paid to the hospital according to
the Health Insurance Price of April 1996. The survival of
the graft at 90 days was used as an effectiveness endpoint
